Page 80 - Guide de prise en charge de la tuberculose en Tunisie 2018

of Drug Resistant Tuberculosis. 2014.

17. Piubello A, Harouna SH, Souleymane MB, Boukary I, Morou S, Daouda M, et al. High cure
rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no
relapses. Int J Tuberc Lung Dis. 2014;18(10):1188–94.

18. WHO. The shorter MDR-TB regimen, May 2016. (www.who.int)
19. Gegia M, et al. Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic
review and meta-analysis. Lancet Infect Dis. 2016. ii:S1473-3099(16)30407-8. doi:
10.1016/S1473-3099(16)30407-8.

20. WHO treatment guidelines for drug-resistant tuberculosis, 2016 update. (Document
WHO/HTM/ TB/2016.04). Geneva: World Health Organization; 2016
(http://who.int/tb/areas-of-work/drugresistant-tb/treatment/resources/en/, accessed 02
March 2017).
21. WHO treatment guidelines for isoniazid-resistant tuberculosis- Supplement to the WHO
treatment guidelines for drug-resistant tuberculosis. World Health Organization, 2018.
(https://creativecommons.org/licenses/by-nc-sa/3.0/igo).
22. Rapid Communication: Key changes to treatment of multidrug- and rifampicin-resistant
tuberculosis (MDR/RR-TB). World Health Organization, August 2018.
(https://creativecommons.org/licenses/by-nc-sa/3.0/igo).

80 | P a ge